Union Levosulpiride Tablet

Adult dose

Adults: Administer 25 mg of levosulpiride orally 3 times daily before meals.

This medication should not be administered to women who are pregnant or may become pregnant and to breastfeeding women. Patients with gastrointestinal bleeding, mechanical obstruction, or perforation should not be given this medication as its gastrointestinal motility-promoting effects may be harmful. Patients with certain tumors such as pheochromocytoma should not use this medication as it may induce hypertension. Patients with a history of allergy or intolerance to this medication should avoid its use. This medication is unsuitable for patients with liver disease, patients in the manic phase of bipolar disorder, and patients with malignant breast disease, so it should not be administered to them. Caution should be exercised in administering to patients with hypertension, children, and elderly patients due to a higher risk of side effects. This medication may affect the endocrine system and cause symptoms such as amenorrhea, galactorrhea, and gynecomastia; if these symptoms occur, the medication should be stopped immediately. Extrapyramidal symptoms such as tremors, tongue twisting, and restlessness may rarely occur, and if they do, the medication should be discontinued. Long-term use may result in tardive dyskinesia symptoms such as involuntary movements around the mouth, so caution is needed. Gastrointestinal side effects such as dry mouth, heartburn, nausea, vomiting, diarrhea, and constipation have been reported, so patients should be informed if these symptoms occur. Cardiovascular side effects such as hypertension or arrhythmias may also occur, so cardiac condition should be closely monitored. Rarely, a serious side effect known as Neuroleptic Malignant Syndrome may occur, characterized by high fever, muscle rigidity, and changes in consciousness; if these symptoms occur, medication should be stopped immediately, and emergency treatment should be sought. Any allergic reactions such as rashes or swelling should result in immediate discontinuation of the medication. Drowsiness, dizziness, and insomnia may occur during treatment, so it is advisable to avoid tasks requiring concentration such as driving or operating machinery. This medication may interact with other drugs, particularly anticholinergics, narcotic analgesics, digitalis preparations, other benzamide drugs, psychiatric medications, drugs that prolong the QT interval, and drugs that cause electrolyte disturbances, so caution is advised when taken with these substances. Women who are pregnant or breastfeeding should not take this medication, and elderly patients may need dose adjustments and careful monitoring of side effects due to potential renal impairment. Additionally, due to its anti-emetic effects, this medication may mask vomiting symptoms from other causes, so symptoms should be closely monitored, and caution is needed for long-term use due to reported reproductive toxicity and tumorigenicity in animal studies.

• Amenorrhea
• hyperprolactinemia
• gynecomastia
• tremors
• tongue twisting
• anxiety
• involuntary movements around the mouth
• thirst
• heartburn
• nausea

This medication should be stored in a tightly sealed container to protect it from air and moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication and prevents degradation.

Appearance

White round tablet

Package unit

Domestic use: 30 tablets/bottle, 300 tablets/bottle, 1000 tablets/bottle